Pharmaceutical Firm
 

A pharmaceutical firm was interested in broadening its portfolio to other product segments, including allied, non-pharmaceutical products, and, potentially, targeted medical devices. Other criteria included increasing margins and expanding geographic scope to enable cross selling opportunities.

Vericours helped determine specific acquisition criteria and identified a series of promising product market segments. Once specific product market segments were chosen through a strategic options workshop with the client, we identified a series of possible acquisition candidates and valuation models and the acquiree value propositions for each. We then ranked the candidates with the client and provided support in approaching the targeted firms. When firms indicated interest, we supported subsequent negotiations and regulatory filings where necessary.

After each successful acquisition we provided post merger integration support for firms located in the US and Europe. We also created cross selling strategies where appropriate and accompanying implementation plans. Where evident, we identified key barriers to success, such as lack of access by current sales force or channel and key sales training needs.

 

Copyright © 2004 Vericours, Inc. All rights reserved.